Our solutions
Discovery

Preclinical

Clinical

CMC

Digital
Omics & biomarkers

Biosciences

Compound screening

Pharmacology

Chemistry

Discovery DMPK

Therapeutic areas

Development DMPK

Preclinical safety

Bioanalysis

Clinical services phase 1 & 2

Bioanalysis

Biomarkers

Clinical trial supply services

Drug substances

Drug products

Pharmaceutical analytical services

Clinical trial supply services

Regulatory

Life science database

Digital science technologies

Molecular modelling

Cheminformatics & ML

Bioinformatics & omics data analysis
Our approach
Our story & philosophy

Integrated solutions

Our clients
History

Certificates

Animal management

News

Dermatology

Oncology

Modalities

Research phases

Testimonials

Working with us
Resources
Scientific publications

Brochures

Posters

Videos

Events

Contact Us
Search

Search

Our solutions
Our approach
Resources

Businessmen's connections are protected through quality assurance protocols, processes, standards, certifications, methods, monitoring, and auditing

Whistleblower

Uncover misconduct safely:

Platform for

Nuvisan GmbH - Whistleblower platform

Platform for

Nuvisan ICB GmbH - Whistleblower platform

Discovery

Omics & biomarkers
Biosciences
Compound screening
Pharmacology
Chemistry
Discovery DMPK
Therapeutic areas

Preclinical

Development DMPK
Preclinical safety
Bioanalysis

Clinical

Clinical services phase 1 & 2
Bioanalysis
Biomarkers
Clinical trial supply services

CMC

Drug substances
Drug products
Pharmaceutical analytical solutions
Clinical trial supply services
Regulatory

Integrated solutions

Dermatology
Oncology
Modalities
Research phases

Digital

Life science database
Digital science technologies
Molecular modelling
Cheminformatics & ML
Bioinformatics & omics data analysis

Our approach

Our story & philosophy
Integrated solutions
Our clients
Careers

Resources

Scientific publications
Brochures
Posters
Videos
Events

ALS Limited

About us
Careers
Governance
Investors
News & media
Sustainability

A division of ALS Limited

FOLLOW US

Privacy & cookie policy
Legal notice
Whistleblower
Accessibility statement

ALS Copyright © 2025. All Rights Reserved.

v.1.1.1203